Thromboelastographic evaluation of hemostatic function in dogs with dilated cardiomyopathy
This study aimed to evaluate the hemostatic function by thromboelastography (TEG) and determine if there was an association between the changes in hemostatic parameters and serum cardiac troponin I (cTnI) in dogs with dilated cardiomyopathy (DCM). DCM was diagnosed by echocardiography in 19 dogs. Ten healthy dogs were selected as controls. Myocardial injury was confirmed by increased serum cTnI levels. Coagulation was assessed by TEG evaluating clot kinetics (reaction time [R] and kinetic time [K]), clot strengthening (alpha [α] angle and G value), platelet function (maximum amplitude [MA] and coagulation-index [CI]), clot stability (LY30, the percentage of lysis 30 min after MA), and global clotting times (activated partial thromboplastin time [aPTT] and prothrombin time [PT]). Dogs with DCM had higher R and K times but lower MA, α-angle, G, and CI compared to controls (P < 0.05). LY30 and PT did not statistically differ between groups, but the aPTT in dogs with DCM was higher than that of the controls. Serum cTnI (median [range], ng/mL) was higher in dogs with DCM (0.25 [0.13-3.1]) than in healthy dogs (0.03 [0.01-0.06]). There was no statistical relation between cTnI and coagulation parameters. This study showed that alterations of the coagulation status in dogs with DCM could develop independently of serum cTnI elevations.
___
- Wendy WA. Cardiovascular Disease in Small Animal Medicine.
3rd ed. London, UK: Manson Publishing; 2011.
- Martin MW, Stafford Johnson MJ, Strehlau G, King JN. Canine
dilated cardiomyopathy: a retrospective study of prognostic
findings in 367 clinical cases. J Small Anim Pract 2010; 8: 428-
436.
- Oyama MA. Canine cardiomyopathy. In: Smith F, Tilley L,
Oyama M, Sleeper M, editors. Manual of Canine and Feline
Cardiology. 5th ed. St. Louis, MO, USA: Elsevier; 2016. pp.
141-152.
- Dukes-McEwan J, Borgarelli M, Tidholm A, Vollmar AC,
Häggström J. Proposed guidelines for the diagnosis of canine
idiopathic dilated cardiomyopathy. Journal of Veterinary
Cardiology 2003; 5: 7-19.
- Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D,
Arnett D, Moss AJ, Seidman CE, Young JB. Contemporary
definitions and classification of the cardiomyopathies.
Circulation 2006; 11; 113: 1807-1816.
- Sbarouni E, Bradshaw A, Andreotti F, Tuddenham E,
Oakley CM, Cleland JG. Relationship between hemostatic
abnormalities and neuroendocrine activity in heart failure. Am
Heart J 1994; 127: 607-612.
- De Lorenzo F, Saba N, Kakkar VV. Blood coagulation in patients
with chronic heart failure: evidence for hypercoagulable state
and potential for pharmacological intervention. Drugs 2003;
63: 565-576.
- Tarnow I, Falk T, Tidholm A, Martinussen T, Jensen AL, Olsen
LH, Pedersen HD, Kristensen AT. Hemostatic biomarkers in
dogs with chronic congestive heart failure. J Vet Intern Med
2007; 21: 451-457.
- Lubas G, Caldin M, Wiinber B, Kristensen AT. Laboratory
Testing of Coagulation Disorders. In: Weiss DJ, Wardrop KJ,
editors. Schalm’s Veterinary Hematology. 6th ed. Ames, IA,
USA: Wiley-Blackwell; 2010. pp. 1082-1100.
- Bauer N, Eralp O, Moritz A. Establishment of reference
intervals for kaolin-activated thromboelastography in dogs
including an assessment of the effects of sex and anticoagulant
use. J Vet Diagn Invest 2009; 21: 641-648.
- Eralp O, Yilmaz Z, Failing K, Moritz A, Bauer N. Effect of
experimental endotoxemia on thrombelastography parameters,
secondary and tertiary hemostasis in dogs. J Vet Int Med 2011;
25: 524-531.
- Kocatürk M, Eralp İnan O, Levent P, Yılmaz Z. Protective effects
of S- adenosylmethionine (SAMe) and silybin on hepatorenal
and hemostatic functions in dogs with endotoxemia. Turk J Vet
Anim Sci 2016; 40: 788-796.
- Eralp İnan O, Kocatürk M, Mecitoğlu Z, Yılmaz Z.
Thromboelastographic evaluation of coagulation in a dog with
anticoagulant rodenticide intoxication. Kafkas Univ Vet Fak
2016; 22: 477-478.
- Oyama MA. Using cardiac biomarkers in veterinary practice.
Vet Clin North Am Small Anim Pract 2013; 43: 1261-1272.
- Çakıroğlu D, Meral Y, Bakırel U, Kazancı D. Cardiac troponin
levels in dogs with dilate cardiomyopathy. Kafkas Univ Vet Fak
2009; 15: 13-17.
- Güneş V, Uyanık F, Eren M, Kibar M, Aslan Ö, Onmaz AC.
The rapid analyses of cardiac troponins in dogs with dilated
cardiomyopathy, distemper or parvovirus infection. Kafkas
Univ Vet Fak 2014; 20: 921-927.
- Wendy WA. Cardiovascular system disorders. In: Nelson RW,
Couto CG, editors. Small Animal Internal Medicine. 5th ed. St.
Louis, MO, USA: Elsevier; 2013. pp. 130-158.
- Boon JA. Veterinary Echocardiography. 2nd ed. Ames, IA,
USA: Wiley-Blackwell; 2010.
- Mongirdiene A, Kursvietiene L, Kasauskas A. The coagulation
system changes in patients with chronic heart failure. Medicina
(Kaunas) 2010; 46: 642-647.
- Tarnow I, Kristensen AT, Olsen LH, Pedersen HD. Assessment
of changes in hemostatic markers in Cavalier King Charles
Spaniels with myxomatous mitral valve disease. Am J Vet Res
2004; 65: 1644-1652.
- Bédard C, Lanevschi-Pietersma A, Dunn M. Evaluation of
coagulation markers in the plasma of healthy cats and cats with
asymptomatic hypertrophic cardiomyopathy. Vet Clin Pathol
2007; 36: 167-172.
- Davis CJ, Gurbel PA, Gattis WA, Fuzaylov SY, Nair GV,
O’Connor CM, Serebruany VL. Hemostatic abnormalities in
patients with congestive heart failure: diagnostic significance
and clinical challenge. Int J Cardiol 2000; 75: 15-21.
- Prihirunkit K, Sastravaha A, Lekcharoensuk C, Chanloinapha
P. Hemostatic markers in congestive heart failure dogs with
mitral valve disease. Journal of Veterinary Medicine 2014;
2014: 589873.
- Otto CM, Rieser TM, Brooks MB, Russell MW. Evidence of
hypercoagulability in dogs with parvoviral enteritis. J Am Vet
Med Assoc 2000; 217: 1500-1504.
- Kristensen AT, Wiinberg B, Jessen LR, Adreasen E, Jensen
AL. Evaluation of human recombinant tissue factor-activated
thromboelastography in 49 dogs with neoplasia. J Vet Intern
Med 2008; 22: 140-147.
- Sinnott VB, Otto CM. Use of thromboelastography in dogs
with immune- mediated hemolytic anemia: 39 cases (2000–
2008). J Vet Emerg Crit Care 2009; 19: 484-488.
- Chung I, Lip GY. Platelets and heart failure. Eur Heart J 2006;
27: 2623-2631.
- Tarnow I, Andreasen SHS, Olsen LH, Moesgaard SG,
Rasmussen CE, Kristensen AT, Falk BT. Congestive heart
failure in dogs is associated with enhanced platelet-leukocyte
aggregates - a marker for platelet activation. J of Vet Int Med
2010; 24: 673-673.
- Tarnow I, Kristensen A, Olsen LH, Falk T, Haubro L, Pedersen
LG, Pedersen HD. Dogs with heart diseases causing turbulent
high-velocity blood flow have changes in platelet function and
von Willebrand factor multimer distribution. J Vet Intern Med
2005; 19: 515-522.